UroGen Pharma Ltd. — Form 8-K
Filed August 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
UroGen Pharma filed an 8-K on August 20, 2026 reporting a period event on August 18, 2026. The filing discloses Item 8.01 (Other Events) but the actual content of the event is not provided in this document index. No counterparties, dollar amounts, share counts, dates beyond the filing date, or substantive business changes are specified in the available filing metadata.
Why this rating
Routine 8-K filing with no disclosed material details. Metadata shows filing structure only; actual event substance unavailable to assess impact on $620M market cap company.
Extracted items
See more from August 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.